UroGen Pharma (URGN) Change in Inventory (2017 - 2026)

UroGen Pharma (URGN) has 9 years of Change in Inventory data on file, last reported at $4.5 million in Q1 2026.

• Quarterly Change in Inventory rose 372.27% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (up 3741.79% YoY) and the FY2025 annual result came in at $7.2 million, up 103.63% from the prior year.
• Change in Inventory eased to $4.5 million in Q1 2026, from $8.1 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $8.1 million in Q4 2025 to a low of -$1.6 million in Q1 2025.
• A 5-year average of $997529.4 and a median of $199000.0 in 2024 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory jumped 1600.0% — and 2025, when it sank 332.16%.
• Tracing URGN's Change in Inventory over 5 years: stood at -$283000.0 in 2022, then jumped by 337.1% to $671000.0 in 2023, then surged by 143.37% to $1.6 million in 2024, then surged by 397.43% to $8.1 million in 2025, then tumbled by 45.13% to $4.5 million in 2026.
• The last three Change in Inventory figures came in at $4.5 million (Q1 2026), $8.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.